tiprankstipranks
Advertisement
Advertisement
China NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
PremiumCompany AnnouncementsChina NT Pharma Says Director’s Judicial Records Tied to Settled Subsidiary Loan, No Material Impact Seen
1M ago
China NT Pharma details board and committee structure
Premium
Company Announcements
China NT Pharma details board and committee structure
1M ago
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
Premium
Company Announcements
China NT Pharma Reveals Past Unannounced Connected Transactions and Compliance Lapses
1M ago
China NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
PremiumCompany AnnouncementsChina NT Pharma Narrows Annual Loss Despite Revenue Decline in 2025
3M ago
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
Premium
Company Announcements
China NT Pharma Narrows Expected 2025 Loss on One-Off Debt-Settlement Gain
3M ago
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
Premium
Company Announcements
China NT Pharma Completes Share-Financed Acquisition and Reshapes Shareholding Structure
3M ago
China NT Pharma to Raise HK$65 Million via Convertible Bonds for Working Capital and Debt Repayment
PremiumCompany AnnouncementsChina NT Pharma to Raise HK$65 Million via Convertible Bonds for Working Capital and Debt Repayment
4M ago
China NT Pharma Advances AI Bone Health Pivot and Secures Liquidity Support After Going-Concern Warning
Premium
Company Announcements
China NT Pharma Advances AI Bone Health Pivot and Secures Liquidity Support After Going-Concern Warning
5M ago
China NT Pharma Shareholders Approve Major Share Issue for Medical Device Acquisition
Premium
Company Announcements
China NT Pharma Shareholders Approve Major Share Issue for Medical Device Acquisition
5M ago

Trending

Name
Price
Price Change
S&P 500
―
Dow Jones
―
Nasdaq 100
―